Medical marijuana laws and driving under the influence of marijuana and alcohol.

Addiction
David S FinkDeborah S Hasin

Abstract

Medical marijuana law (MML) enactment in the United States has been associated with increased cannabis use but lower traffic fatality rates. We assessed the possible association of MML and individual-level driving under the influence of cannabis (DUIC) and also under the influence of alcohol (DUIA). Three cross-sectional U.S. adult surveys: The National Longitudinal Alcohol Epidemiologic Survey (NLAES; 1991-1992), the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC; 2001-2002), and the NESARC-III (2012-2013). The total n was 118 497: 41 764, 41 184, and 35 549 from NLAES, NESARC, and NESARC-III, respectively. Across the three surveys, similar questions in the Alcohol Use Disorder and Associated Disabilities Interview Schedule assessed DUIC and DUIA. Ever-MML states enacted MML between 1991-1992 and 2012-2013 (overall period). Early-MML states enacted MML between 1991-1992 and 2001-2002 (early period). Late-MML states enacted MML between 2001-2002 and 2012-2013 (late period). MML effects on change in DUIC and DUIA prevalence were estimated using a difference-in-differences specification to compare changes in MML and other states. From 1991-1992 to 2012-2013, DUIC prevalence nearly doubled (from 1.02% to 1...Continue Reading

References

Feb 1, 1994·Accident; Analysis and Prevention·P N Rogers, S E Schoenig
Jun 1, 1997·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·F Willeke, T Lehnert
Jul 13, 1999·The Journal of Clinical Psychiatry·I KurzthalerW W Fleischhacker
Sep 7, 2002·Archives of General Psychiatry·Deborah S Hasin, Bridget F Grant
May 6, 2004·JAMA : the Journal of the American Medical Association·Wilson M ComptonFrederick S Stinson
Feb 26, 2005·Molecular Interventions·Steven R HurshJames H Woods
Dec 17, 2005·Journal of Analytical Toxicology·Patrick MuraThierry Hauet
May 31, 2007·Journal of Drug Education·Randi J AlterRobert Greene
Mar 3, 2012·Journal of Health Economics·Benjamin Crost, Santiago Guerrero
Jun 16, 2012·The Lancet Oncology·Bryant Furlow
Jul 24, 2012·American Journal of Community Psychology·Bridget FreisthlerScott E Martin
May 29, 2013·JAMA Pediatrics·George Sam WangKennon Heard
Aug 2, 2013·BMJ : British Medical Journal·Owen Dyer
Dec 24, 2013·Journal of Policy Analysis and Management : [the Journal of the Association for Public Policy Analysis and Management]·D Mark Anderson, Daniel I Rees
Jan 31, 2014·American Journal of Epidemiology·Joanne E Brady, Guohua Li
Sep 14, 2014·Journal of Analytical Toxicology·Fiona J Couper, Brianna L Peterson
Dec 9, 2014·JAMA : the Journal of the American Medical Association·Andrew A MonteKennon J Heard
Feb 7, 2015·Journal of Drug Policy Analysis·Rosalie Liccardo PaculaAnne Boustead
Jul 7, 2015·Drug and Alcohol Dependence·Rebecca L HartmanMarilyn A Huestis
Oct 27, 2015·JAMA Psychiatry·Deborah S HasinBridget F Grant
Sep 2, 2016·MMWR. Surveillance Summaries : Morbidity and Mortality Weekly Report. Surveillance Summaries·Alejandro AzofeifaRob Lyerla
Dec 1, 2014·Injury Epidemiology·Kristin WongGuohua Li
Dec 28, 2016·JAMA Pediatrics·Magdalena CerdáDeborah S Hasin
Feb 23, 2017·The New England Journal of Medicine·Beau Kilmer
May 2, 2017·Journal of Drug Issues·Christopher CambronCharles B Fleming
Aug 12, 2017·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Patricia A Cavazos-RehgLaura Bierut
Sep 14, 2017·JAMA Psychiatry·Mark OlfsonBridget F Grant

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.